> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pediatric Oncology Drugs Panel Meeting
- URL: https://www.fdaweb.com/pediatric-oncology-drugs-panel-meeting/
- Published: 2019-05-06T12:00:00.000Z
- Updated: 2026-09-15T01:24:50.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144029

*Federal Register* notice: FDA has announced a 6/20 meeting of the Oncologic Drugs Advisory Committee’s Pediatric Oncology Subcommittee. During the morning session, panel members will review and discuss two pediatric molecular targets: (**1**) Targets linked to cell lineage and (**2**) targets on normal immune cells and cells in the tumor microenvironment. During the afternoon session, information will be presented to gauge investigator interest in exploring potential pediatric development plans for two products in various stages of development for adult cancer indications. The subcommittee will consider and discuss issues concerning diseases to be studied, patient populations to be included, and possible study designs in developing these products for pediatric use. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-05-06/pdf/2019-09212.pdf?ref=fdaweb.com).